前列腺癌患者使用长视野扫描的单独延迟[68Ga]Ga-PSMA-11 PET/CT的图像质量与可行性
本研究纳入56例前列腺癌患者,于注射后1小时行早期长视野PET/CT、3小时行延迟长视野PET/CT,评估单独延迟[68Ga]Ga-PSMA-11长视野PET/CT的图像质量与诊断效能。延迟显像图像质量满足临床诊断标准,病灶SUVmax和靶本比均高于早期显像,并在14例(25%)患者中检出额外病灶,改变了疾病分期和管理计划。
要点
- 延迟[68Ga]Ga-PSMA-11长视野PET/CT图像质量满足临床诊断标准。
- 延迟显像病灶SUVmax为11.0(2.3-193.6),高于早期7.0(2.0-124.3),P<0.001。
- 延迟显像靶本比为3.3(0.5-62.2),高于早期1.7(0.3-30.7),P<0.001。
核心结论
- 延迟[68Ga]Ga-PSMA-11长视野PET/CT图像质量满足临床诊断前提条件。
- 与需行早期和延迟显像的[68Ga]Ga-PSMA-11标准PET/CT相比,单独延迟[68Ga]Ga-PSMA-11长视野PET/CT简化了检查流程并提高患者依从性。
研究设计与样本
- 研究纳入2020年12月至2021年7月期间接受[68Ga]Ga-PSMA-11长视野PET/CT扫描的56例前列腺癌患者。
- 所有患者均在注射后1小时行早期长视野PET/CT,并在注射后3小时行延迟长视野PET/CT。
- 分析单独延迟[68Ga]Ga-PSMA-11长视野PET/CT的图像质量与诊断效能。
主要发现
- 延迟[68Ga]Ga-PSMA-11长视野PET/CT图像质量满意,满足临床诊断基准。
- 与早期显像相比,延迟显像病灶SUVmax为11.0(2.3-193.6) vs 早期7.0(2.0-124.3),P<0.001。
- 与早期显像相比,延迟显像靶本比为3.3(0.5-62.2) vs 早期1.7(0.3-30.7),P<0.001。
- 与早期显像相比,延迟[68Ga]Ga-PSMA-11长视野PET/CT在14例患者(25%)中检出额外病灶,导致疾病分期和管理计划改变。
关键数值与推荐
- 延迟[68Ga]Ga-PSMA-11长视野PET/CT图像质量满足临床诊断基准。
- 延迟显像病灶SUVmax为11.0(2.3-193.6),早期为7.0(2.0-124.3),P<0.001。
- 延迟显像靶本比为3.3(0.5-62.2),早期为1.7(0.3-30.7),P<0.001。
- 延迟显像在14例患者(25%)中检出早期显像未检出的额外病灶。
临床怎么用
- 作者认为,单独延迟[68Ga]Ga-PSMA-11长视野PET/CT可用于前列腺癌患者,简化检查方案并提高患者依从性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Previous studies have demonstrated that delayed [68 Ga]Ga-PSMA PET/CT imaging improves lesion detection compared to early [68 Ga]Ga-PSMA PET/CT in patients with prostate cancer. However, the sole use of delayed [68 Ga]Ga-PSMA PET/CT has been limited due to the insufficient number of photons obtained with standard PET/CT scanners. The combination of early and delayed [68 Ga]Ga-PSMA standard PET/CT may be considered, and it is challenging to incorporate into a high-demand clinical setting. Long field-of-view (LFOV) PET/CT scanners have higher sensitivity compared to standard PET/CT. However, it remains unknown whether the image quality of solitary delayed [68 Ga]Ga-PSMA LFOV PET/CT imaging is adequate to satisfy clinical diagnostic requirements. Therefore, the purpose of this study was to evaluate the image quality of delayed [68 Ga]Ga-PSMA LFOV PET/CT and examine the feasibility of utilizing delayed [68 Ga]Ga-PSMA LFOV PET/CT imaging alone in patients with prostate cancer. METHODS: The study sample consisted of 56 prostate cancer patients who underwent [68 Ga]Ga-PSMA-11 LFOV PET/CT scanning between December 2020 and July 2021. All patients were subjected to early LFOV PET/CT imaging at 1-h post-injection as well as delayed LFOV PET/CT imaging at 3-h post-injection using [68 Ga]Ga-PSMA-11. The image quality and diagnostic efficiency of solitary delayed [68 Ga]Ga-PSMA-11 LFOV PET/CT imaging was analyzed. RESULTS: The results showed that delayed [68 Ga]Ga-PSMA-11 LFOV PET/CT yielded satisfactory image quality that fulfilled clinical diagnostic benchmarks. Compared to early imaging, delayed [68 Ga]Ga-PSMA-11 LFOV PET/CT demonstrated heightened lesion SUVmax values (11.0 [2.3-193.6] vs. 7.0 [2.0-124.3], P < 0.001) and superior tumor-to-background ratios (3.3 [0.5-62.2] vs. 1.7 [0.3-30.7], P < 0.001). Additionally, delayed [68 Ga]Ga-PSMA-11 LFOV PET/CT detected supplementary lesions in 14 patients (25%) compared to early imaging, resulting in modifications to disease staging and management plans. CONCLUSIONS: In summary, the findings indicate that the image quality of delayed [68 Ga]Ga-PSMA-11 LFOV PET/CT is satisfactory for meeting clinical diagnostic prerequisites. The use of solitary delayed [68 Ga]Ga-PSMA-11 LFOV PET/CT imaging in prostate cancer simplifies the examination protocol and improves patient compliance, compared to [68 Ga]Ga-PSMA-11 standard PET/CT which necessitates both early and delayed imaging.
引用
- Yu X, Xu L, Huang G, et al. The image quality and feasibility of solitary delayed [68 Ga]Ga-PSMA-11 PET/CT using long field-of-view scanning in patients with prostate cancer. EJNMMI Res. 2024. PMID: 38319452. doi:10.1186/s13550-024-01076-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。